These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3114806)

  • 1. Effects of single or multiple choice trials per session on drug discrimination performance.
    Tomie A; Peoples L; Wagner GC
    Psychopharmacology (Berl); 1987; 92(4):529-35. PubMed ID: 3114806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discrimination training with a single choice trial per session.
    Tomie A; Loukas E; Stafford I; Peoples L; Wagner GC
    Psychopharmacology (Berl); 1985; 86(1-2):217-22. PubMed ID: 3927359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational exposure to methylmercury retards choice in transition in aging rats.
    Newland MC; Reile PA; Langston JL
    Neurotoxicol Teratol; 2004; 26(2):179-94. PubMed ID: 15019952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.
    White JM; Holtzman SG
    Psychopharmacology (Berl); 1983; 80(1):1-9. PubMed ID: 6408661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias of morphine generalization to cyclazocine by drug history.
    Paule MG; Wenger GR
    Pharmacol Biochem Behav; 1986 Mar; 24(3):479-83. PubMed ID: 3703883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-choice drug discrimination in the rat: morphine, cyclazocine and saline.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1981 May; 217(2):254-62. PubMed ID: 7229971
    [No Abstract]   [Full Text] [Related]  

  • 8. OR discrimination: a new drug discrimination method.
    Colpaert FC; Janssen PA
    Eur J Pharmacol; 1982 Feb; 78(1):141-4. PubMed ID: 7075662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.
    Prus AJ; Philibin SD; Pehrson AL; Porter JH
    Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discrimination and cross generalization between two methylxanthines.
    Modrow HE; Holloway FA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):425-9. PubMed ID: 4048237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative effects of cyclazocine in the squirrel monkey.
    Schaefer GJ; Holtzman SG
    J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.
    Holtzman SG
    Psychopharmacology (Berl); 1982; 77(4):295-300. PubMed ID: 6813889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentazocine, cyclazocine, and nalorphine as discriminative stimuli.
    Hirschhorn ID
    Psychopharmacology (Berl); 1977 Nov; 54(3):289-94. PubMed ID: 413147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
    Preston KL; Bigelow GE; Bickel W; Liebson IA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
    Colpaert FC; Janssen PA
    Psychopharmacology (Berl); 1986; 90(2):222-8. PubMed ID: 3097702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement.
    Barrett RJ; Caul WF; Huffman EM; Smith RL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):289-96; discussion 297-303. PubMed ID: 7862836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase.
    Porsolt RD; Pawelec C; Roux S; Jalfre M
    Neuropharmacology; 1984 May; 23(5):569-73. PubMed ID: 6429563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
    Stadler JR; Caul WF; Barrett RJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discrimination analysis of pseudoephedrine in rats.
    Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.